missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ CCG 1423
Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
Description
CCG 1423 is a Rho/SRF pathway inhibitor; stimulates apoptosis of a melanoma cell line overexpressing RhoC (A375M2). Suppresses Rho-dependent invasion of PC-3 prostate cancer cells in vitro and inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells. When used in combination with Retinoic acid, LY 294002 and Pyridone 6, it induces intermediate mesoderm differentiation from ESCs.
Specifications
Specifications
| Purity | >99% |
| Quantity | 10 mg |
| Product Type | CCG 1423 |
| Molecular Weight (g/mol) | 454.75 |
| Inhibitors | Rho GTPase Inhibitors |
For Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction